Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Garzón Olarte, Martín Alonso"'
Publikováno v:
1. Narváez-Rivera C.A, Cortez-Hernández J.A, González-González J.L, et al. Mexican Consensus on Portal Hypertension R.M. Rev Gastroenterol Mex 2013; 78:92-113 2. De Franchis R; Baveno V Faculty. Expanding consensus in portal hypertension. Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63:743-752. 3. Blasco A, Forns X, Carrion JA, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006; 43:492-499. 4. Kovalak M, Lake J, Mattek N, et al. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc 2007; 65:82-88. 5. Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353:2254-2261. 6. Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003; 38:266-272. 7. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017; 65: 1: 310-335. 8. G. D’Amico,R. de Franchis Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology, 2003; 38: 599-612. 9. Abraldes JG, Villanueva C, Banares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol, 2008; 48: 229-236. 10. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology, 2007; 46:922-938. 11. Boscha J, Abraldesa JG, Albillos A, Aracil G. Portal hypertension: Recommendations for evaluation and treatment. Gastroenterol Hepatol. 2012; 35:421-50. 12. Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 2014; 146: 2:412-419. 13. Fortune B, Garcia-Tsao G, Ciarleglio M, Deng Y, Fallon MB, Sigal S, et al. Child-Turcotte-Pugh Class is best at stratifying risk in variceal hemorrhage: analysis of a U.S. multi-center prospective study. J Clin Gastroenterol 2016; 51(5):446-53. 14. Tandon P, Abraldes JG, Keough A, Bastiampillai R, Jayakumar S, Carbonneau M, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics. Clin Gastroenterol Hepatol 2015;13: 6:1189-1196. 15. Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci JC, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol; 2008;48: 2:229-236. 16. Martínez JD, Garzón MA, Rey MH, et al. Factores pronósticos asociados con mortalidad en pacientes cirróticos con sangrado varicoso en dos hospitales de Bogotá, Colombia. Rev Col Gastroenterol. 2016; 31: 4: 331-336. 17. Gómez D, Garzón M, Martínez JD, et al. Várices esofágicas: experiencia clínica en un hospital de referencia regional. Rev Col Gastroenterol. 2003; 18: 1. 18. Zuidema, Yeo. Schackelford. Enfermedades del aparato digestivo 5ª Edición. Ed Médica Panamericana. 19. Khanna R, Sarin SK. Non-cirrhotic portal hypertension – Diagnosis and management. J Hepatol. 2014; 60(2):421-41. 20. Cyriac Abby Philips* and Amrish Sahney Oesophageal and gastric varices: historical aspects, classification and grading: everything in one place. Gastroenterol Rep (Oxf). 2016; 4(3): 186–195. 21. Snady H, Feinman L. Prediction of variceal hemorrhage: A prospective study. Am J Gastroentrol 1988;83(5):519–25. 22. Calès P, Zabotto B, Meskens C, et al. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology 1990; 98(1):156–62. 23. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. N Engl J Med 1991; 324(25):1779–84. 24. Zoli M, Merkel C, Magalotti D, et al. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology 1996; 24(5):1047–52. 25. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92(7):1081–91. 26. Jutabha R, Jensen D, Martin P, et al. A randomized, prospective study of prophylactic rubber band ligation compared to propranolol for prevention of first variceal hemorrhage in cirrhotics with large esophageal varices. Gastrointest Endosc 2001; 53:568. 27. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16(6):1343–1349. 28. Arakawa M, Masuzaki T, Okuda K. Pathomorphology of esophageal and gastric varices. Semin Liver Dis 2002;22(1):73–81. 29. Iwase H, Maeda O, Shimada M, et al. Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding. Gastroint Endosc 2001; 53(6):585–59 30. Kovalak M, Lake J, Mattek N, et al. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. 65 (Gastrointest Endosc 2007), pp. 828. 31. Lujano S, Valdés L, Corral M, et al. Factores asociados a la presencia de várices en pacientes cirróticos envíados a endoscopia de tamizaje, 21 (Endoscopia 2009), pp. 38-4. 32. Negreanu L. Busegeanu C. Trandafir D. Dragomir P. Portal hypertensive gastropathy. 43 (Rom J Intern Med 2005), pp. 3-8. 33. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis., 362 (N Engl J Med 2010), pp. 823-32 34. Garcia-Tsao G, Lim J, et al. Management and treatment of patients with cirrhosis and portal hypertension: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program., 104 (Am J Gastroenterol 2009), pp. 1802-1829.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La hipertensión portal se define como el aumento en el gradiente de presión porto sistémica > a 5 mmHg, es la anomalía hemodinámica asociada a complicaciones más graves en cirrosis. La hemorragia varicosa es una emergencia médic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::246011599bfcb68db9ff43062f77c636
http://repository.urosario.edu.co/handle/10336/19125
http://repository.urosario.edu.co/handle/10336/19125
Autor:
Suarez, Oscar, Pérez, María, Daza, Rodrigo, Hernandez, Geovanny, Salinas, Carolina, Ceballos, Jorge, De Leon, Enrique P., Mugnier, Jacqueline, Beltrán, Oscar, Varón, Adriana, Garzón Olarte, Martín Alonso
Publikováno v:
H.A.Edmondson,“Differentialdiagnosisoftumorsandtumorlikelesionsofliverininfancyandchildhood,”A.M.A.American JournalofDiseasesofChildren,vol.91,no.2,pp.168–186,1956.
V.Maniaci,B.R.Davidson,K.Rollesetal.,“Fibrolamellarhepatocellularcarcinoma-Prolongedsurvivalwithmultimodality therapy,”European Journal of Surgical Oncology, vol. 35,no. 6, pp.617–621,2009.
M.Torbenson,“FibrolamellarCarcinoma:2012Update,”Scientifica,vol.2012,ArticleID743790,15pages,2012.
E.J.GrossmanandJ.M.Millis,“Livertransplantationfornonhepatocellularcarcinomamalignancy:indications,limitations, andanalysisofthecurrentliterature,”LiverTransplantation,vol. 16,no.8,pp.930–942,2010.
V. Paradis, “Histopathology of hepatocellular carcinoma,” in Multidisciplinary Treatment of Hepatocellular Carcinoma, vol. 190 of Recent Results in Cancer Research, pp. 21–32, Springer, Berlin,Germany,2013.
G. M. Fonseca, A. D. Varella, F. F. Coelho, E. S. Abe, R. B. Dumarco, and P. Herman, “Downstaging and resection after neoadjuvant therapyfor fibrolamellar hepatocellularcarcinoma,”WorldJournalofGastrointestinalSurgery,vol.6,no.6, p.107,2014.
D.Ganeshan,J.Szklaruk,V.Kundra,A.Kaseb,A.Rashid,and K. Elsayes, “Imaging features of fibrolamellar hepatocellular carcinoma,”AmericanJournalofRoentgenology,vol.202,no.3, pp.544–552,2014.
T.Eggert,K.A.McGlynn,A.Duffy,M.P.Manns,T.F.Greten, andS.F.Altekruse,“Fibrolamellarhepatocellularcarcinomain theUSA,2000–2010:adetailedreportonfrequency,treatment andoutcomebasedonthesurveillance,epidemiology,andend Results database,” United European Gastroenterology Journal, vol.1,no.5,pp.351–357,2013.
H.Cornella,C.Alsinet,S.Sayolsetal.,“Uniquegenomicprofile of fibrolamellar hepatocellular carcinoma,” Gastroenterology, vol.148,no.4,pp.806–818.e10,2015.
G. G. Malouf, S. Job, V. Paradis et al., “Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrinesignature,”Hepatology,vol.59,no.6,pp.2228–2237, 2014.
T. Pawlik and K. Lafaro, “Fibrolamellar hepatocellular carcinoma: current clinical perspectives,” Journal of Hepatocellular Carcinoma,p.151.
T. Kanai, T. Takabayashi, Y. Kawano, S. Kuramochi, and N. Miyazawa,“Acaseofpostoperativerecurrenceoffibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacityinayoungJapanesefemale,”JapaneseJournalofClinical Oncology,vol.34,no.6,pp.346–351,2004.
S. K. Asrani and N. F. Larusso, “Fibrolamellar hepatocellular carcinoma presenting with budd-chiari syndrome, right atrial thrombus, and pulmonary emboli,” Hepatology, vol. 55, no. 3, pp.977-978,2012.
J.Lloreta,C.Vadell,X.Fabregat,andS.Serrano,“Fibrolamellar hepatictumorwithneurosecretoryfeaturesandsystemicdepositionofAAamyloid,”UltrastructuralPathology,vol.18,no.1-2, pp.287–292,1994.
J. A. Espinosa, A. Merlo, M.-O. Arafeh, and G. Munene, “An unusualcaseofjaundice:Biliarytumorthrombusinfibrolamellar hepatocellular carcinoma,” International Journal of Surgery CaseReports,vol.36,pp.50–54,2017.
K. M. Tezer, B. Yalc ¸´ın, N. B¨ uy¨ukpamukc¸u, G. Kale, and M. B¨uy¨ukpamukc¸u,“Fibrolamellarhepatocellularcarcinomawith skeletalmetastases,”PediatricHematologyandOncology,vol.18, no.4,pp.273–278,2001.
N.A.Villa,R.Pannala,D.O.Faigeletal.,“Metastaticfibrolamellar hepatocellular carcinoma to the pancreas,” Case Reports in Gastroenterology,vol.9,pp.266–271,2015.
S.H.Ciurea,E.Matei,C.S.Stanescuetal.etal.,“Fibrolamellar hepatocellularcarcinomawithovarianmetastasis-anunusual presentation.Rom,”JournalofMorphologyandEmbryology,vol. 58,pp.187-92,2017.
O.Soreide,A.Czemiak,H.Bradpiece,S.Bloom,andL.Blumgart,“Characteristicsoffibrolamellarhepatocellularcarcinoma. A study of nine cases and a review of the literature,” The AmericanJournalofSurgery,vol.151,no.4,pp.518–523,1986.
D. L. Lildballe, K. Q. T. Nguyen, S. S. Poulsen, H. O. Nielsen, and E. Nexo, “Haptocorrin as marker of disease progression infibrolamellarhepatocellularcarcinoma,”EuropeanJournalof SurgicalOncology,vol.37,no.1,pp.72–79,2011.
R. K. G. Do, A. McErlean, C. S. Ang, R. P. Dematteo, and G. K. Abou-Alfa, “CT and MRI of primary and metastatic fibrolamellar carcinoma: A case series of 37 patients,” British JournalofRadiology,vol.87,no.1040,ArticleID20140024,2014.
S. Liu, K. Wah Chan, J. Tong, Y. Wang, B. Wang, and L. Qiao, “PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellularcarcinoma:A casereport and a summaryofrecentliterature,”QJM:AnInternationalJournalof Medicine,vol.104,no.6,pp.477–483,2011.
C.G.Roth andD.G.Mitchell,“Hepatocellularcarcinomaand otherhepaticmalignancies:MRimaging,”RadiologicClinicsof NorthAmerica,vol.52,no.4,pp.683–707,2014.
S. Sethi, N. Tageja, J. Singh et al., “Hyperammonemic encephalopathy:Ararepresentationoffibrolamellarhepatocellularcarcinoma,”TheAmericanJournaloftheMedicalSciences, vol.338,no.6,pp.522–524,2009.
C. Berger, P. Dimant, L. Hermida, F. Paulin, M. Pereyra, and M.Tejo,“Hyperammonemicencephalopathyandfibrolamellar hepatocellularcarcinoma,”Medicina(Argentina),vol.72,no.5, pp.425–427,2012.
R. A. Sulaiman and T. Geberhiwot, “Fibrolamellar Hepatocellular Carcinoma Mimicking Ornithine Transcarbamylase Deficiency,”inJIMDReportsVolume16,vol.16ofJIMDReports, pp.47–50,SpringerBerlinHeidelberg,Berlin,Heidelberg,2014.
C. I. Chapuy, I. Sahai, R. Sharma, A. X. Zhu, and O. N. Kozyreva,“Hyperammonemicencephalopathyassociatedwith fibrolamellar hepatocellular carcinoma: Case report, literature review,andproposedtreatmentalgorithm,”TheOncologist,vol. 21,no.4,pp.514–520,2016.
M. N. Mavros, S. C. Mayo, O. Hyder, and T. M. Pawlik, “A systematic review: Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma,” Journal of the AmericanCollegeofSurgeons,vol.215,no.6,pp.820–830,2012.
W. T. Kassahun, “Contemporary management of fibrolamellar hepatocellular carcinoma: Diagnosis, treatment, outcome, prognosticfactors,andrecentdevelopments,”WorldJournalof SurgicalOncology,vol.14,no.1,articleno.151,2016.
A. D. Pinna, S. Iwatsuki, R. G. Lee et al., “Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation,”Hepatology,vol.26,no.4,pp.877–883,1997.
L.G.Atienza,J.Berger,X.Meietal.,“Livertransplantationfor fibrolamellarhepatocellularcarcinoma:Anationalperspective,” JournalofSurgicalOncology,vol.115,no.3,pp.319–323,2017.
A.O.Kaseb,M.Shama,I.H.Sahinetal.,“Prognosticindicators and treatmentoutcome in94 casesof fibrolamellar hepatocellularcarcinoma,”Oncology(Switzerland),vol.85,no.4,pp.197– 203,2013.
B. Njei, “Fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: Better 5-year survival or artifactualresultofresearchmethodology?”Gut,vol.63,no.9, pp.1374-1375,2014
A. E. Alsina, “Successful Liver Transplantation for HyperammonemicFibrolamellarHepatocellularCarcinoma,”ACGCase ReportsJournal,vol.3,no.4,2016
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
V.Maniaci,B.R.Davidson,K.Rollesetal.,“Fibrolamellarhepatocellularcarcinoma-Prolongedsurvivalwithmultimodality therapy,”European Journal of Surgical Oncology, vol. 35,no. 6, pp.617–621,2009.
M.Torbenson,“FibrolamellarCarcinoma:2012Update,”Scientifica,vol.2012,ArticleID743790,15pages,2012.
E.J.GrossmanandJ.M.Millis,“Livertransplantationfornonhepatocellularcarcinomamalignancy:indications,limitations, andanalysisofthecurrentliterature,”LiverTransplantation,vol. 16,no.8,pp.930–942,2010.
V. Paradis, “Histopathology of hepatocellular carcinoma,” in Multidisciplinary Treatment of Hepatocellular Carcinoma, vol. 190 of Recent Results in Cancer Research, pp. 21–32, Springer, Berlin,Germany,2013.
G. M. Fonseca, A. D. Varella, F. F. Coelho, E. S. Abe, R. B. Dumarco, and P. Herman, “Downstaging and resection after neoadjuvant therapyfor fibrolamellar hepatocellularcarcinoma,”WorldJournalofGastrointestinalSurgery,vol.6,no.6, p.107,2014.
D.Ganeshan,J.Szklaruk,V.Kundra,A.Kaseb,A.Rashid,and K. Elsayes, “Imaging features of fibrolamellar hepatocellular carcinoma,”AmericanJournalofRoentgenology,vol.202,no.3, pp.544–552,2014.
T.Eggert,K.A.McGlynn,A.Duffy,M.P.Manns,T.F.Greten, andS.F.Altekruse,“Fibrolamellarhepatocellularcarcinomain theUSA,2000–2010:adetailedreportonfrequency,treatment andoutcomebasedonthesurveillance,epidemiology,andend Results database,” United European Gastroenterology Journal, vol.1,no.5,pp.351–357,2013.
H.Cornella,C.Alsinet,S.Sayolsetal.,“Uniquegenomicprofile of fibrolamellar hepatocellular carcinoma,” Gastroenterology, vol.148,no.4,pp.806–818.e10,2015.
G. G. Malouf, S. Job, V. Paradis et al., “Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrinesignature,”Hepatology,vol.59,no.6,pp.2228–2237, 2014.
T. Pawlik and K. Lafaro, “Fibrolamellar hepatocellular carcinoma: current clinical perspectives,” Journal of Hepatocellular Carcinoma,p.151.
T. Kanai, T. Takabayashi, Y. Kawano, S. Kuramochi, and N. Miyazawa,“Acaseofpostoperativerecurrenceoffibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacityinayoungJapanesefemale,”JapaneseJournalofClinical Oncology,vol.34,no.6,pp.346–351,2004.
S. K. Asrani and N. F. Larusso, “Fibrolamellar hepatocellular carcinoma presenting with budd-chiari syndrome, right atrial thrombus, and pulmonary emboli,” Hepatology, vol. 55, no. 3, pp.977-978,2012.
J.Lloreta,C.Vadell,X.Fabregat,andS.Serrano,“Fibrolamellar hepatictumorwithneurosecretoryfeaturesandsystemicdepositionofAAamyloid,”UltrastructuralPathology,vol.18,no.1-2, pp.287–292,1994.
J. A. Espinosa, A. Merlo, M.-O. Arafeh, and G. Munene, “An unusualcaseofjaundice:Biliarytumorthrombusinfibrolamellar hepatocellular carcinoma,” International Journal of Surgery CaseReports,vol.36,pp.50–54,2017.
K. M. Tezer, B. Yalc ¸´ın, N. B¨ uy¨ukpamukc¸u, G. Kale, and M. B¨uy¨ukpamukc¸u,“Fibrolamellarhepatocellularcarcinomawith skeletalmetastases,”PediatricHematologyandOncology,vol.18, no.4,pp.273–278,2001.
N.A.Villa,R.Pannala,D.O.Faigeletal.,“Metastaticfibrolamellar hepatocellular carcinoma to the pancreas,” Case Reports in Gastroenterology,vol.9,pp.266–271,2015.
S.H.Ciurea,E.Matei,C.S.Stanescuetal.etal.,“Fibrolamellar hepatocellularcarcinomawithovarianmetastasis-anunusual presentation.Rom,”JournalofMorphologyandEmbryology,vol. 58,pp.187-92,2017.
O.Soreide,A.Czemiak,H.Bradpiece,S.Bloom,andL.Blumgart,“Characteristicsoffibrolamellarhepatocellularcarcinoma. A study of nine cases and a review of the literature,” The AmericanJournalofSurgery,vol.151,no.4,pp.518–523,1986.
D. L. Lildballe, K. Q. T. Nguyen, S. S. Poulsen, H. O. Nielsen, and E. Nexo, “Haptocorrin as marker of disease progression infibrolamellarhepatocellularcarcinoma,”EuropeanJournalof SurgicalOncology,vol.37,no.1,pp.72–79,2011.
R. K. G. Do, A. McErlean, C. S. Ang, R. P. Dematteo, and G. K. Abou-Alfa, “CT and MRI of primary and metastatic fibrolamellar carcinoma: A case series of 37 patients,” British JournalofRadiology,vol.87,no.1040,ArticleID20140024,2014.
S. Liu, K. Wah Chan, J. Tong, Y. Wang, B. Wang, and L. Qiao, “PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellularcarcinoma:A casereport and a summaryofrecentliterature,”QJM:AnInternationalJournalof Medicine,vol.104,no.6,pp.477–483,2011.
C.G.Roth andD.G.Mitchell,“Hepatocellularcarcinomaand otherhepaticmalignancies:MRimaging,”RadiologicClinicsof NorthAmerica,vol.52,no.4,pp.683–707,2014.
S. Sethi, N. Tageja, J. Singh et al., “Hyperammonemic encephalopathy:Ararepresentationoffibrolamellarhepatocellularcarcinoma,”TheAmericanJournaloftheMedicalSciences, vol.338,no.6,pp.522–524,2009.
C. Berger, P. Dimant, L. Hermida, F. Paulin, M. Pereyra, and M.Tejo,“Hyperammonemicencephalopathyandfibrolamellar hepatocellularcarcinoma,”Medicina(Argentina),vol.72,no.5, pp.425–427,2012.
R. A. Sulaiman and T. Geberhiwot, “Fibrolamellar Hepatocellular Carcinoma Mimicking Ornithine Transcarbamylase Deficiency,”inJIMDReportsVolume16,vol.16ofJIMDReports, pp.47–50,SpringerBerlinHeidelberg,Berlin,Heidelberg,2014.
C. I. Chapuy, I. Sahai, R. Sharma, A. X. Zhu, and O. N. Kozyreva,“Hyperammonemicencephalopathyassociatedwith fibrolamellar hepatocellular carcinoma: Case report, literature review,andproposedtreatmentalgorithm,”TheOncologist,vol. 21,no.4,pp.514–520,2016.
M. N. Mavros, S. C. Mayo, O. Hyder, and T. M. Pawlik, “A systematic review: Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma,” Journal of the AmericanCollegeofSurgeons,vol.215,no.6,pp.820–830,2012.
W. T. Kassahun, “Contemporary management of fibrolamellar hepatocellular carcinoma: Diagnosis, treatment, outcome, prognosticfactors,andrecentdevelopments,”WorldJournalof SurgicalOncology,vol.14,no.1,articleno.151,2016.
A. D. Pinna, S. Iwatsuki, R. G. Lee et al., “Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation,”Hepatology,vol.26,no.4,pp.877–883,1997.
L.G.Atienza,J.Berger,X.Meietal.,“Livertransplantationfor fibrolamellarhepatocellularcarcinoma:Anationalperspective,” JournalofSurgicalOncology,vol.115,no.3,pp.319–323,2017.
A.O.Kaseb,M.Shama,I.H.Sahinetal.,“Prognosticindicators and treatmentoutcome in94 casesof fibrolamellar hepatocellularcarcinoma,”Oncology(Switzerland),vol.85,no.4,pp.197– 203,2013.
B. Njei, “Fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: Better 5-year survival or artifactualresultofresearchmethodology?”Gut,vol.63,no.9, pp.1374-1375,2014
A. E. Alsina, “Successful Liver Transplantation for HyperammonemicFibrolamellarHepatocellularCarcinoma,”ACGCase ReportsJournal,vol.3,no.4,2016
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Fibrolamellar hepatocarcinoma is an infrequent liver tumor, currently considered to be a variant different from hepatocarcinoma. The differences lie in genomic alterations, a greater prevalence of fibrolamellar hepatocarcinoma in young patients, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ceb0d66501106757e916ccb509593b9
http://repository.urosario.edu.co/handle/10336/18871
http://repository.urosario.edu.co/handle/10336/18871
Autor:
Galindo Orrego, Pablo, Bejarano Rengifo, Janeth, Labrador López, Christian, Hernández Cely, Geovanny, Beltrán Galvis, Oscar Alfredo, Garzón Olarte, Martín Alonso, Ponce de León Chaux, Enrique, Ceballos Hurtado, Jorge Alberto, Salinas Gómez, Diana Carolina, Varón Puerta, Adriana
Publikováno v:
Revista de Gastroenterología del Perú, Volume: 37, Issue: 4, Pages: 391-393, Published: OCT 2017
La fístula biliopleurobronquial (FBB) es una comunicación anormal entre la vía biliar y el árbol bronquial. Es una condición infrecuente, generalmente secundaria a un proceso infeccioso local o a un evento traumático. La bilioptisis es patognom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______619::dbe3c430c245a511c16e0abcbded0b24
http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292017000400017&lng=en&tlng=en
http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292017000400017&lng=en&tlng=en
Autor:
Galindo Orrego, Pablo, Bejarano, Janeth, Hernández, Geovanny, Labrador, Christian, Beltrán, Oscar, Garzón Olarte, Martín Alonso, Ponce de León, Enrique, Ceballos, Jorge, Salinas, Carolina, Varón, Adriana
Publikováno v:
Liao G-Q, Wang H, Zhu G-Y, Zhu KB,Lv F-X, Tai S. World Journal of Gastroenterology. 2011;17(33):3842-3849.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
La fístula biliopleurobronquial (FBB) es una comunicación anormal entre la vía biliar y el árbol bronquial. Es una condición infrecuente, generalmente secundaria a un proceso infeccioso local o a un evento traumático. La bilioptisis es patognom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f01b275370a65f4ba4a0c5c1499b4316
Autor:
Pardo, Rodrigo, Sabbagh, Luis, Otero, William, Prieto, Jhon, Garzón Olarte, Martín Alonso, Varón, Adriana, Mendoza, Yuly, Galindo Ángel, Andrés Felipe, Beltrán, Oscar
Publikováno v:
Méndez N,. Gutiérrez Y, Chávez N et al. Hígado graso no alcohólico y esteatohepatitis no alcohólica. Conceptos actuales. Revista de Gastroenterología de México. 2010;75:143S-148S.
Diagnóstico y Tratamiento de la Enfermedad Hepática Grasa No Alcohólica del Adulto. México: Secretaría de Salud; 08/07/2014 .
Chalasani N., Younossi Z., Lavine J., Mae Diehl A., Brunt A., Cussi K., Charlton M., Sanyal A., The diagnosis and Managment of Non-alcoholic fatty liver disease: Practice Guideline by the American Association for the study of Liver Disease, American College of Gastroenterology, and The American Gastroenterological Association. Hepatology 2012;55:2005-2023
AGREE C. INSTRUMENTO AGREE II. Instrumento para la evaluación de guías de práctica clínica[en línea] GuíaSalud. 2009.
Guía Metodológica para la elaboración de Guías de Práctica Clínica con Evaluación Económica en el Sistema General de Seguridad Social en Salud Colombiano. In: Ministerio de la Protección Social C, Centro de Estudios e Investigación en Salud de la Fundación Santa Fe de Bogotá editor. Bogotá, D.C.2013.
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol.2007;7(1):10.
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Wiley Online Library; 2008.
Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669-77
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011 Dec;43(8):617-49.
Kwok R, Tse YK, Wong GL, Ha Y, Lee AU, Ngu MC, Chan HL, Wong VW. Systematic review with metaanalysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther. 2014 Feb;39(3):254-69.
Rakoski MO, Singal, AG, Rogers MAM, Conjeevaram H. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2010; 32: 1211–1221.
Li Y, Liu L, Wang B, Wang J, Chen D. Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomedical Report I: 2013;57-64.
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685
Du J, Ma Y, Yu CH, Li YM. Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2014; 20(2): 569-577
Zeng T, Zhang CL, Zhao XL, Xie KQ. Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. Eur J Gastroenterol Hepatol. 2014 Jun;26(6):646-53
Wu S, Li L, Wang J. Ursodeoxycholic acid for nonalcoholic seatohepatitis. Eur J Gastroenterol Hepatol 2012, 24:1247–1253.
Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2013; 19(40): 6911-6918.
Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H. Statins for non-alcoholic fatty liver dis-ease and non-alcoholic steatohepatitis. Cochrane Database of Systematic Reviews 2013.
Eliades M, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013; 38: 246–254
Mummadi RR, Kasturi KS, Chennareddygair S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clinical Gastro and Hepatol 2008;6:1396-1402.
Chavez-Tapia NC, Tellez-Avila FI, Barrientose-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database of Systematic Reviews 2010, Issue 1. Art No: CD007340. DOI:10:1002/14641858.
Thoma C, Day CP,Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012;56:255-266.
Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012;57:157-166.
Chiu S, Sievenpiper JL, Souza RJ, et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. European Journal of Clinical Nutrition 2014;68:416–423.
Zelber-Sagi S. Et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Translational Research 2015: 165 (3):428-435
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43(8):617-649.
Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014;12(3):394-402.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Diagnóstico y Tratamiento de la Enfermedad Hepática Grasa No Alcohólica del Adulto. México: Secretaría de Salud; 08/07/2014 .
Chalasani N., Younossi Z., Lavine J., Mae Diehl A., Brunt A., Cussi K., Charlton M., Sanyal A., The diagnosis and Managment of Non-alcoholic fatty liver disease: Practice Guideline by the American Association for the study of Liver Disease, American College of Gastroenterology, and The American Gastroenterological Association. Hepatology 2012;55:2005-2023
AGREE C. INSTRUMENTO AGREE II. Instrumento para la evaluación de guías de práctica clínica[en línea] GuíaSalud. 2009.
Guía Metodológica para la elaboración de Guías de Práctica Clínica con Evaluación Económica en el Sistema General de Seguridad Social en Salud Colombiano. In: Ministerio de la Protección Social C, Centro de Estudios e Investigación en Salud de la Fundación Santa Fe de Bogotá editor. Bogotá, D.C.2013.
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol.2007;7(1):10.
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Wiley Online Library; 2008.
Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669-77
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011 Dec;43(8):617-49.
Kwok R, Tse YK, Wong GL, Ha Y, Lee AU, Ngu MC, Chan HL, Wong VW. Systematic review with metaanalysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther. 2014 Feb;39(3):254-69.
Rakoski MO, Singal, AG, Rogers MAM, Conjeevaram H. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2010; 32: 1211–1221.
Li Y, Liu L, Wang B, Wang J, Chen D. Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomedical Report I: 2013;57-64.
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685
Du J, Ma Y, Yu CH, Li YM. Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2014; 20(2): 569-577
Zeng T, Zhang CL, Zhao XL, Xie KQ. Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. Eur J Gastroenterol Hepatol. 2014 Jun;26(6):646-53
Wu S, Li L, Wang J. Ursodeoxycholic acid for nonalcoholic seatohepatitis. Eur J Gastroenterol Hepatol 2012, 24:1247–1253.
Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2013; 19(40): 6911-6918.
Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H. Statins for non-alcoholic fatty liver dis-ease and non-alcoholic steatohepatitis. Cochrane Database of Systematic Reviews 2013.
Eliades M, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013; 38: 246–254
Mummadi RR, Kasturi KS, Chennareddygair S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clinical Gastro and Hepatol 2008;6:1396-1402.
Chavez-Tapia NC, Tellez-Avila FI, Barrientose-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database of Systematic Reviews 2010, Issue 1. Art No: CD007340. DOI:10:1002/14641858.
Thoma C, Day CP,Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012;56:255-266.
Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012;57:157-166.
Chiu S, Sievenpiper JL, Souza RJ, et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. European Journal of Clinical Nutrition 2014;68:416–423.
Zelber-Sagi S. Et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Translational Research 2015: 165 (3):428-435
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43(8):617-649.
Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014;12(3):394-402.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Objetivo: Brindar una guía de práctica clínica basada con la evidencia más reciente para el diagnóstico y tratamiento de la Enfermedad Hepática Grasa No alcohólica teniendo en cuenta la efectividad y seguridad de las intervenciones dirigidas a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae67d441d8ee71e02ad03feea982c523
http://repository.urosario.edu.co/handle/10336/12348
http://repository.urosario.edu.co/handle/10336/12348
Autor:
Martínez Marín, Julián David, Garzón Olarte, Martín Alonso, Lizarazo Rodríguez, Jorge Iván, Marulanda Gómez, Juan Carlos, Molano Villa, Juan Carlos, Rey Tovar, Mario Humberto, Hormaza, Natán
Publikováno v:
Revista Colombiana de Gastroenterologia, Volume: 25, Issue: 4, Pages: 344-348, Published: 30 DEC 2010
Se realizó un estudio observacional descriptivo de los pacientes sometidos a esofagogastroduodenoscopia durante los años 2004 y 2009 en el Hospital Universitario de La Samaritana y con diagnóstico histológico de cáncer gástrico gástrico (CG).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______618::4cb184661ba9355dba42d3a55823bf52
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-99572010000400004&lng=en&tlng=en
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-99572010000400004&lng=en&tlng=en
Autor:
Garzón Olarte, Martín Alonso, Granados, Carlos, Martínez, Julián, Rey, Mario H, Molano, Juan, Guevara, Luis, Marulanda, Juan
Publikováno v:
Revista Colombiana de Gastroenterologia, Volume: 19, Issue: 2, Pages: 86-93, Published: 30 JUN 2004
La ascitis es la complicación más común de la cirrosis hepática. Hasta 50% de los pacientes con cirrosis compensada desarrollarán ascitis en los siguientes 10 años de su evolución, y su presencia se asocia con una pobre supervivencia. Algunos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______618::909f05d393fdbb5373d0530a18aeddc9
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-99572004000200005&lng=en&tlng=en
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-99572004000200005&lng=en&tlng=en
Publikováno v:
Fagiuoli S, Colli A, Bruno R, Burra P, Craxì A, Gaeta GB, et al. Management of infections in cirrhotic patients: Report of a Consensus Conference. Dig Liver Dis. 2014;46(3):204-12.
Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310-24.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-60.
Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol. 2015;7(3):304-14.
Koulaouzidis A. Diagnosis of spontaneous bacterial peritonitis: An update on leucocyte esterase reagent strips. World J Gastroenterol. 2011;17(9):1091-4.
Mendler MH, Agarwal A, Trimzi M, Madrigal E, Tsushima M, Joo E, et al. A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method. J Hepatol. 2010;53(3):477-83.
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.
Kutter D, Figueiredo G, Klemmer L. Chemical detection of leukocytes in urine by means of a new multiple test strip. J Clin Chem Clin Biochem. 1987;25(2):91-4.
Castellote J, López C, Gornals J, Tremosa G, Fariña ER, Baliellas C, et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of Reagent Strips. Hepatology. 2003;37(4):893-6.
Thévenot T, Cadranel J-F, Nguyen-Khac E, Tilmant L, Tiry C, Welty S, et al. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips. Eur J Gastroenterol Hepatol. 2004;16(6):579-83.
Sapey T, Kabissa D, Fort E, Laurin C, Mendler MH. Instant diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips: Nephur-TestR vs. MultistixSGR. Liver Int. 2005;25(2):343-8.
Sapey T, Mena E, Fort E, Laurin C, Kabissa D, Runyon BA, et al. Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroenterol Hepatol. 2005;20(2):187-92.
Kim DY, Kim JH, Chon CY, Han K-H, Ahn SH, Kim JK, et al. Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int. 2005;25(6):1197-201.
Braga LL, Souza MH, Barbosa AM, Furtado FM, Campelo PA, Araújo Filho AH. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients in northeastern Brazil by use of rapid urine-screening test. Sao Paulo Med J. 2006;124(3):141-4.
Campillo B, Richardet JP, Dupeyron C. Diagnostic value of two reagent strips (Multistix® 8 SG and Combur® 2 LN) in cirrhotic patients with spontaneous bacterial peritonitis and symptomatic bacterascites. Gastroenterol Clin Biol. 2006;30(3):446-52.
Rerknimitr R, Rungsangmanoon W, Kongkam P, Kullavanijaya P. Efficacy of leukocyte esterase dipstick test as a rapid test in diagnosis of spontaneous bacterial peritonitis. World J Gastroenterol. 2006;12(44):7183-7.
Ribeiro TC, Kondo M, Amaral AC, Parise ER, Bragagnolo Júnior MA, Souza AF. Evaluation of reagent strips for ascitic fluid leukocyte determination: is it a possible alternative for spontaneous bacterial peritonitis rapid diagnosis? Braz J Infect Dis. 2007;11(1):70-4.
Nousbaum JB, Cadranel JF, Nahon P, Khac EN, Moreau R, Thévenot T, et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology. 2007;45(5):1275-81.
Torun S, Dolar E, Yilmaz Y, Keskin M, Kiyici M, Sinirtas M, et al. Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients. World J Gastroenterol. 2007;13(45):6027-30.
Gaya DR, Lyon TDB, Clarke J, Jamdar S, Inverarity D, Forrest EH, et al. Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol. 2007;19(4):289-95.
Nguyen-Khac E, Cadranel JF, Thevenot T, Nousbaum JB. Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients. Aliment Pharmacol Ther. 2008;28(3):282-8.
Chugh K, Agrawal Y, Goyal V, Khatri V, Kumar P. Diagnosing bacterial peritonitis made easy by use of leukocyte esterase dipsticks. Int J Crit Illn Inj Sci. 2015;5(1):32-7.
Téllez-Ávila FI, Chávez-Tapia NC, Franco-Guzmán AM, Uribe M, Vargas-Vorackova F. Rapid diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips in emergency department: Uri-quick clini-10SG® vs. multistix 10SG®. Ann Hepatol. 2012;11(5):696-9.
Koulaouzidis A, Leontiadis GI, Abdullah M, Moschos J, Gasem J, Tharakan J, et al. Leucocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review. Eur J Gastroenterol Hepatol. 2008;20(11):1055-60.
Salinas Gómez D. Caracterización clínica, citoquímica y microbiológica de pacientes cirróticos con peritonitis bacteriana espontánea. Tesis de especialidad. Bogotá, Colombia: Universidad del Rosario; 2014.
Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med. 2010;5 Suppl 1:S37-44.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310-24.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-60.
Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol. 2015;7(3):304-14.
Koulaouzidis A. Diagnosis of spontaneous bacterial peritonitis: An update on leucocyte esterase reagent strips. World J Gastroenterol. 2011;17(9):1091-4.
Mendler MH, Agarwal A, Trimzi M, Madrigal E, Tsushima M, Joo E, et al. A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method. J Hepatol. 2010;53(3):477-83.
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.
Kutter D, Figueiredo G, Klemmer L. Chemical detection of leukocytes in urine by means of a new multiple test strip. J Clin Chem Clin Biochem. 1987;25(2):91-4.
Castellote J, López C, Gornals J, Tremosa G, Fariña ER, Baliellas C, et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of Reagent Strips. Hepatology. 2003;37(4):893-6.
Thévenot T, Cadranel J-F, Nguyen-Khac E, Tilmant L, Tiry C, Welty S, et al. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips. Eur J Gastroenterol Hepatol. 2004;16(6):579-83.
Sapey T, Kabissa D, Fort E, Laurin C, Mendler MH. Instant diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips: Nephur-TestR vs. MultistixSGR. Liver Int. 2005;25(2):343-8.
Sapey T, Mena E, Fort E, Laurin C, Kabissa D, Runyon BA, et al. Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroenterol Hepatol. 2005;20(2):187-92.
Kim DY, Kim JH, Chon CY, Han K-H, Ahn SH, Kim JK, et al. Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int. 2005;25(6):1197-201.
Braga LL, Souza MH, Barbosa AM, Furtado FM, Campelo PA, Araújo Filho AH. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients in northeastern Brazil by use of rapid urine-screening test. Sao Paulo Med J. 2006;124(3):141-4.
Campillo B, Richardet JP, Dupeyron C. Diagnostic value of two reagent strips (Multistix® 8 SG and Combur® 2 LN) in cirrhotic patients with spontaneous bacterial peritonitis and symptomatic bacterascites. Gastroenterol Clin Biol. 2006;30(3):446-52.
Rerknimitr R, Rungsangmanoon W, Kongkam P, Kullavanijaya P. Efficacy of leukocyte esterase dipstick test as a rapid test in diagnosis of spontaneous bacterial peritonitis. World J Gastroenterol. 2006;12(44):7183-7.
Ribeiro TC, Kondo M, Amaral AC, Parise ER, Bragagnolo Júnior MA, Souza AF. Evaluation of reagent strips for ascitic fluid leukocyte determination: is it a possible alternative for spontaneous bacterial peritonitis rapid diagnosis? Braz J Infect Dis. 2007;11(1):70-4.
Nousbaum JB, Cadranel JF, Nahon P, Khac EN, Moreau R, Thévenot T, et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology. 2007;45(5):1275-81.
Torun S, Dolar E, Yilmaz Y, Keskin M, Kiyici M, Sinirtas M, et al. Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients. World J Gastroenterol. 2007;13(45):6027-30.
Gaya DR, Lyon TDB, Clarke J, Jamdar S, Inverarity D, Forrest EH, et al. Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol. 2007;19(4):289-95.
Nguyen-Khac E, Cadranel JF, Thevenot T, Nousbaum JB. Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients. Aliment Pharmacol Ther. 2008;28(3):282-8.
Chugh K, Agrawal Y, Goyal V, Khatri V, Kumar P. Diagnosing bacterial peritonitis made easy by use of leukocyte esterase dipsticks. Int J Crit Illn Inj Sci. 2015;5(1):32-7.
Téllez-Ávila FI, Chávez-Tapia NC, Franco-Guzmán AM, Uribe M, Vargas-Vorackova F. Rapid diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips in emergency department: Uri-quick clini-10SG® vs. multistix 10SG®. Ann Hepatol. 2012;11(5):696-9.
Koulaouzidis A, Leontiadis GI, Abdullah M, Moschos J, Gasem J, Tharakan J, et al. Leucocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review. Eur J Gastroenterol Hepatol. 2008;20(11):1055-60.
Salinas Gómez D. Caracterización clínica, citoquímica y microbiológica de pacientes cirróticos con peritonitis bacteriana espontánea. Tesis de especialidad. Bogotá, Colombia: Universidad del Rosario; 2014.
Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med. 2010;5 Suppl 1:S37-44.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción. La peritonitis bacteriana espontánea requiere un diagnóstico temprano para el inicio de antibioticoterapia. El estudio diagnóstico ideal es el citoquímico del líquido ascítico, el cual puede ser costoso, demorado y de disponibili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045036ea7702a039380b1279f3656a23
https://repository.urosario.edu.co/handle/10336/20877
https://repository.urosario.edu.co/handle/10336/20877
Autor:
Bejarano Rengifo, Janeth
Publikováno v:
Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. The Lancet. 2014;383(9930):1749-61.
Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310-24.
Fagiuoli S, Colli A, Bruno R, Burra P, Craxì A, Gaeta GB, et al. Management of infections in cirrhotic patients: Report of a Consensus Conference. Dig Liver Dis. marzo de 2014;46(3):204-12
Liver EAFTSOT, others. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.
Singal AK, Salameh H, Kamath PS. Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States. Aliment Pharmacol Ther. julio de 2014;40(1):105-12.
Lutz P. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol. 2015;7(3):304
Mendler, M. Agarwal, A. et al. A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method. Journal of Hepatology. 2010; 53(3), 477–483
Koulaouzidis A. Spontaneous bacterial peritonitis. World J Gastroenterol. 2009;15(9):1042
Kutter, D, Figueiredo, G and Klemmer, L. Chemical detection of leukocytes in urine by means of a new multiple test strip. Journal of Clinical Chemistry and Clinical Biochemistry. 1987; 25(2), 91–4.
Castellote J. Rapid diagnosis of spontaneous bacterial peritonitis by use of Reagent Strips. Hepatology. abril de 2003;37(4):893-6.
Thévenot T, Cadranel J-F, Nguyen-Khac E, Tilmant L, Tiry C, Welty S, et al. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips. Eur J Gastroenterol Hepatol. 2004;16(6):579-83
Sapey T, Kabissa D, Fort E, Laurin C, Mendler MH. Instant diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips: Nephur-TestR vs. MultistixSGR. Liver Int. abril de 2005;25(2):343-8.
Sapey T, Mena E, Fort E, Laurin C, Kabissa D, Runyon BA, et al. Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroenterol Hepatol. 2005;20(2):187-92.
Kim DY, Kim JH, Chon CY, Han K-H, Ahn SH, Kim JK, et al. Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int. diciembre de 2005;25(6):1197-201.
Braga LLBC, Souza MHLP de, Barbosa AM de C, Furtado FM, Campelo PAM, Araújo Filho AH de. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients in northeastern Brazil by use of rapid urine-screening test. Sao Paulo Med J. 2006;124(3):141-4.
Campillo B, Richardet J-P, Dupeyron C. Diagnostic value of two reagent strips (Multistix® 8 SG and Combur® 2 LN) in cirrhotic patients with spontaneous bacterial peritonitis and symptomatic bacterascites. Gastroentérologie Clin Biol. 2006;30(3):446-52.
Rerknimitr R, Rungsangmanoon W, Kongkam P, Kullavanijaya P. Efficacy of leukocyte esterase dipstick test as a rapid test in diagnosis of spontaneous bacterial peritonitis. World J Gastroenterol. 2006;12(44):7183.
Ribeiro TC, Kondo M, Amaral ACC, Parise ER, Bragagnolo Júnior MA, Souza AFM de. Evaluation of reagent strips for ascitic fluid leukocyte determination: is it a possible alternative for spontaneous bacterial peritonitis rapid diagnosis? Braz J Infect Dis. 2007;11(1):70-4l.
Nousbaum J-B, Cadranel J-F, Nahon P, Khac EN, Moreau R, Thévenot T, et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology. mayo de 2007;45(5):1275-81.
Torun S, Dolar E, Yilmaz Y, Keskin M, Kiyici M, Sinirtas M, et al. Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients. World J Gastroenterol. 2007;13(45):6027-30.
Gaya DR, Lyon TDB, Clarke J, Jamdar S, Inverarity D, Forrest EH, et al. Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol. 2007;19(4):289-95.
Nguyen-Khac E, Cadranel J-F, Thevenot T, Nousbaum J-B. Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients. Aliment Pharmacol Ther. agosto de 2008;28(3):282-8.
Koulaouzidis A. Diagnosis of spontaneous bacterial peritonitis: An update on leucocyte esterase reagent strips. World J Gastroenterol. 2011;17(9):1091
Chugh K, Agrawal Y, Goyal V, Khatri V, Kumar P. Diagnosing bacterial peritonitis made easy by use of leukocyte esterase dipsticks. Int J Crit Illn Inj Sci. 2015;5(1):32.
Téllez-Ávila, F. et al. Rapid diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips in emergency department: Uri-quick clini-10SG® vs. multistix 10SG®. Annals of Hepatology. 2012; 11(5), 696–699.
Kochanek, K. D et al. National Vital Statistics Reports Deaths : Final Data for 2009. National Center for Health Statistics. 2012; 60(3), 1–117.
Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. abril de 2011;25(2):281-90.
Lefton HB, Rosa A, Cohen M. Diagnosis and Epidemiology of Cirrhosis. Med Clin North Am. julio de 2009;93(4):787-99.
Moore CM. Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol. 2013;5(5):25
Strauss, E and Caly, W. R. Spontaneous bacterial peritonitis: a therapeutic update. Expert Review of Anti-Infective Therapy. 2006; 4(2), 249–60.
Conn, HO. Spontaneous peritonitis and bacteremia in Laennec´s cirrhosis caused by enteric organisms. Arelatively common but rarely recognizeddyndrome.Ann Intern Med. 1964; 60; 568-580
Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 1 de febrero de 2012;61(2):297-310
Al-Osaimi A, Manne V, Sundaram V. Ascites and spontaneous bacterial peritonitis: Recommendations from two United States centers. Saudi J Gastroenterol. 2014;20(5):279
Lee JM, Han K-H, Ahn SH. Ascites and spontaneous bacterial peritonitis: An Asian perspective. J Gastroenterol Hepatol. septiembre de 2009;24(9):1494-503
Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med. octubre de 2010;5(S1):37-44.
Salinas, D. Caracterización clínica, citoquímica y microbiológica de pacientes cirróticos con peritonitis bacteriana en la Fundación Cardioinfantil. Repositorio institucional EdocUR. 2014. Trabajo de grado Especialización Medicina Interna
Obstein, K. L, Campbell, M. S et al. Association Between Model for End-Stage Liver Disease and Spontaneous Bacterial Peritonitis. The American Journal of Gastroenterology. 2007; 102(12), 2732–2736.
Shalimar and Acharya, S. K. Difficult to treat spontaneous bacterial peritonitis. Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation. 2013; 34(1), 7–13.
Butani RC, et al. Rapid diagnosis of infected ascitic fluid using leukocyte esterase dispstick testing. Am J Gastroenterol 2004: 99:532-53.
Vanbiervliet G, et al. Diagnostic accuracy of a rapid urine‑screening test (Multistix 8SG) in cirrhotic patients with spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2002;14:1257‑60
Jha AK, Kumawat DC, Bolya YK, Goenka MK. Multistix 10 SG Leukocyte Esterage Dipstick Testing in Rapid Bedside Diagnosis of Spontaneous Bacterial Peritonitis: A Prospective Study. J Clin Exp Hepatol. septiembre de 2012;2(3):224-8.
Casas DD, Rodriguez E, Lizarzábal M, Fernández J. Valor de la cinta reactiva para el diagnóstico de infecciones del líquido ascitico.Revista de la sociedad Venezolan de Gastroenterología. 2006;60(4):267-272
Dever JB, Sheikh MY. Review article: spontaneous bacterial peritonitis-bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther. 2015;41(11):1116-31.
Koulaouzidis A, Leontiadis GI, Abdullah M, et al. Leucocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review. Eur J Gastroenterol Hepatol. 2008; 20:1055–1060
Balagopal SK et al. Evaluation of leucocyte esterase reagent strip test for the rapid bedside diagnosis of spontaneous bacterialperitonitis. Indian J Gastroenterol. 2010 Mar;29(2):74-7
R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. ISBN 3-900051-07-0 (URL http://www.R-project.org)
Fernández J, Navasa M, Planas R, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007;133(3):818-2
Fernández J, Tandon P, Mensa J, et al. Antibiotic prophylaxis in cirrhosis: Good and bad. Hepatology. 2016;63(6):2019-31.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310-24.
Fagiuoli S, Colli A, Bruno R, Burra P, Craxì A, Gaeta GB, et al. Management of infections in cirrhotic patients: Report of a Consensus Conference. Dig Liver Dis. marzo de 2014;46(3):204-12
Liver EAFTSOT, others. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.
Singal AK, Salameh H, Kamath PS. Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States. Aliment Pharmacol Ther. julio de 2014;40(1):105-12.
Lutz P. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol. 2015;7(3):304
Mendler, M. Agarwal, A. et al. A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method. Journal of Hepatology. 2010; 53(3), 477–483
Koulaouzidis A. Spontaneous bacterial peritonitis. World J Gastroenterol. 2009;15(9):1042
Kutter, D, Figueiredo, G and Klemmer, L. Chemical detection of leukocytes in urine by means of a new multiple test strip. Journal of Clinical Chemistry and Clinical Biochemistry. 1987; 25(2), 91–4.
Castellote J. Rapid diagnosis of spontaneous bacterial peritonitis by use of Reagent Strips. Hepatology. abril de 2003;37(4):893-6.
Thévenot T, Cadranel J-F, Nguyen-Khac E, Tilmant L, Tiry C, Welty S, et al. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips. Eur J Gastroenterol Hepatol. 2004;16(6):579-83
Sapey T, Kabissa D, Fort E, Laurin C, Mendler MH. Instant diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips: Nephur-TestR vs. MultistixSGR. Liver Int. abril de 2005;25(2):343-8.
Sapey T, Mena E, Fort E, Laurin C, Kabissa D, Runyon BA, et al. Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroenterol Hepatol. 2005;20(2):187-92.
Kim DY, Kim JH, Chon CY, Han K-H, Ahn SH, Kim JK, et al. Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int. diciembre de 2005;25(6):1197-201.
Braga LLBC, Souza MHLP de, Barbosa AM de C, Furtado FM, Campelo PAM, Araújo Filho AH de. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients in northeastern Brazil by use of rapid urine-screening test. Sao Paulo Med J. 2006;124(3):141-4.
Campillo B, Richardet J-P, Dupeyron C. Diagnostic value of two reagent strips (Multistix® 8 SG and Combur® 2 LN) in cirrhotic patients with spontaneous bacterial peritonitis and symptomatic bacterascites. Gastroentérologie Clin Biol. 2006;30(3):446-52.
Rerknimitr R, Rungsangmanoon W, Kongkam P, Kullavanijaya P. Efficacy of leukocyte esterase dipstick test as a rapid test in diagnosis of spontaneous bacterial peritonitis. World J Gastroenterol. 2006;12(44):7183.
Ribeiro TC, Kondo M, Amaral ACC, Parise ER, Bragagnolo Júnior MA, Souza AFM de. Evaluation of reagent strips for ascitic fluid leukocyte determination: is it a possible alternative for spontaneous bacterial peritonitis rapid diagnosis? Braz J Infect Dis. 2007;11(1):70-4l.
Nousbaum J-B, Cadranel J-F, Nahon P, Khac EN, Moreau R, Thévenot T, et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology. mayo de 2007;45(5):1275-81.
Torun S, Dolar E, Yilmaz Y, Keskin M, Kiyici M, Sinirtas M, et al. Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients. World J Gastroenterol. 2007;13(45):6027-30.
Gaya DR, Lyon TDB, Clarke J, Jamdar S, Inverarity D, Forrest EH, et al. Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol. 2007;19(4):289-95.
Nguyen-Khac E, Cadranel J-F, Thevenot T, Nousbaum J-B. Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients. Aliment Pharmacol Ther. agosto de 2008;28(3):282-8.
Koulaouzidis A. Diagnosis of spontaneous bacterial peritonitis: An update on leucocyte esterase reagent strips. World J Gastroenterol. 2011;17(9):1091
Chugh K, Agrawal Y, Goyal V, Khatri V, Kumar P. Diagnosing bacterial peritonitis made easy by use of leukocyte esterase dipsticks. Int J Crit Illn Inj Sci. 2015;5(1):32.
Téllez-Ávila, F. et al. Rapid diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips in emergency department: Uri-quick clini-10SG® vs. multistix 10SG®. Annals of Hepatology. 2012; 11(5), 696–699.
Kochanek, K. D et al. National Vital Statistics Reports Deaths : Final Data for 2009. National Center for Health Statistics. 2012; 60(3), 1–117.
Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. abril de 2011;25(2):281-90.
Lefton HB, Rosa A, Cohen M. Diagnosis and Epidemiology of Cirrhosis. Med Clin North Am. julio de 2009;93(4):787-99.
Moore CM. Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol. 2013;5(5):25
Strauss, E and Caly, W. R. Spontaneous bacterial peritonitis: a therapeutic update. Expert Review of Anti-Infective Therapy. 2006; 4(2), 249–60.
Conn, HO. Spontaneous peritonitis and bacteremia in Laennec´s cirrhosis caused by enteric organisms. Arelatively common but rarely recognizeddyndrome.Ann Intern Med. 1964; 60; 568-580
Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 1 de febrero de 2012;61(2):297-310
Al-Osaimi A, Manne V, Sundaram V. Ascites and spontaneous bacterial peritonitis: Recommendations from two United States centers. Saudi J Gastroenterol. 2014;20(5):279
Lee JM, Han K-H, Ahn SH. Ascites and spontaneous bacterial peritonitis: An Asian perspective. J Gastroenterol Hepatol. septiembre de 2009;24(9):1494-503
Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med. octubre de 2010;5(S1):37-44.
Salinas, D. Caracterización clínica, citoquímica y microbiológica de pacientes cirróticos con peritonitis bacteriana en la Fundación Cardioinfantil. Repositorio institucional EdocUR. 2014. Trabajo de grado Especialización Medicina Interna
Obstein, K. L, Campbell, M. S et al. Association Between Model for End-Stage Liver Disease and Spontaneous Bacterial Peritonitis. The American Journal of Gastroenterology. 2007; 102(12), 2732–2736.
Shalimar and Acharya, S. K. Difficult to treat spontaneous bacterial peritonitis. Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation. 2013; 34(1), 7–13.
Butani RC, et al. Rapid diagnosis of infected ascitic fluid using leukocyte esterase dispstick testing. Am J Gastroenterol 2004: 99:532-53.
Vanbiervliet G, et al. Diagnostic accuracy of a rapid urine‑screening test (Multistix 8SG) in cirrhotic patients with spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2002;14:1257‑60
Jha AK, Kumawat DC, Bolya YK, Goenka MK. Multistix 10 SG Leukocyte Esterage Dipstick Testing in Rapid Bedside Diagnosis of Spontaneous Bacterial Peritonitis: A Prospective Study. J Clin Exp Hepatol. septiembre de 2012;2(3):224-8.
Casas DD, Rodriguez E, Lizarzábal M, Fernández J. Valor de la cinta reactiva para el diagnóstico de infecciones del líquido ascitico.Revista de la sociedad Venezolan de Gastroenterología. 2006;60(4):267-272
Dever JB, Sheikh MY. Review article: spontaneous bacterial peritonitis-bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther. 2015;41(11):1116-31.
Koulaouzidis A, Leontiadis GI, Abdullah M, et al. Leucocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review. Eur J Gastroenterol Hepatol. 2008; 20:1055–1060
Balagopal SK et al. Evaluation of leucocyte esterase reagent strip test for the rapid bedside diagnosis of spontaneous bacterialperitonitis. Indian J Gastroenterol. 2010 Mar;29(2):74-7
R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. ISBN 3-900051-07-0 (URL http://www.R-project.org)
Fernández J, Navasa M, Planas R, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007;133(3):818-2
Fernández J, Tandon P, Mensa J, et al. Antibiotic prophylaxis in cirrhosis: Good and bad. Hepatology. 2016;63(6):2019-31.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción. La peritonitis bacteriana espontánea (PBE) requiere un diagnóstico temprano para el inicio de antibioticoterapia. El diagnóstico se basa en el estudio citoquímico del líquido ascítico, éste toma horas para su realización y tien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b36ac1379eb2fcf583d5287fd81bb5bd
http://repository.urosario.edu.co/handle/10336/14149
http://repository.urosario.edu.co/handle/10336/14149
Publikováno v:
Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; Vol 58 no 19. Hyattsville, MD: National Center for Health Statistics; 2010.
Asrani S, Kamath P, Pedersen R, et al. Liver related mortality in the US is underestimated. Hepatology 2010; 52:408; A169.
Garcia-Tsao et al. Management and treatment of patients with cirrhosis and portal hypertension. Am J Gastroenterol 2009; 104:1802–1829.
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology 2010 vol. 53: 397–417.
Fernadez J, Gustot T. Managment of bacterial infections in cirrhosis. Journal of Hepatology 2012, S1–S12.
Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorganic failure in cirrhosis. Semin Liver Dis 2008;28:26–42.
Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med (2010) 5 (Suppl 1):S37–S44
Koulaouzidis A, Bhat S, Karagiannidis A, Tan W, Linaker B. Spontaneous bacterial peritonitis Postgrad Med J 2007;83:379–383.
France ́s R, Muñoz C, Zapater P, et al. Bacterial DNA activates cell mediated immune response and NO overproduction in peritoneal macrophage from patients with cirrhosis and ascites. Gut 2004;53:860–4.
Horinek E, Fish D. Spontaneous bacterial peritonitis. Advanced critical care 2009 Vol 20 No 2 April-June.
Such J, Ruyon B. Spontaneous bacterial peritonitis. Clinical infectious diseases 1998;27:669-76.
Desai A, Reau N, Reddy G, Te H, Mohanty S, Satoskar R, DeVoss A, Jensen D. Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease. Ther Adv Gastroenterol (2010) 5(5) 275–283.
Deschênes M, Villeneuve J. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol 1999;94:2193-2197. 14)Bhat G, Vandana K, Bhatia S, Suvarna D, Pai C. Spontaneous ascetic fluid infection in liver cirrhosis bacteriological profile and response to antibiotic therapy. Indian J Gastroenterol. 2013 Mar 21.
Tandon P, Delisle A, Topla J Garcia-Tsao G. High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center. Clinical gastroenterology and hepatology 2012; 10:1291–1298.
Riggio O, Angeloni S. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis. World J Gastroenterol 2009 August 21; 15(31): 3845-3850.
Navasa M, Casafont F, Clemente G, Guarner C, de la Mata M, Planas R, Solà R, Suh J Consenso sobre peritonitis bacteriana espontánea en la cirrosis hepática: diagnóstico, tratamiento y profilaxis. Gastroenterol Hepatol 2001; 24: 37-46.
Abd Elaal M, Zaghloul S Gouda Bakr H, Abdou Ashour M, Hady H, Khalifa N, Amr G. Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis. Arab Journal of Gastroenterology 13 (2012) 65–70.
Said A. Al-Busafi, McNabb J, Farag A, Hilzenrat N. Clinical Manifestations of Portal Hypertension International Journal of Hepatology. Vol 2012, Article ID 203794, 10 pages.
Bendtsen F, Grønbæk H, Bach J, Aagaard N, Schmidt L, Møller S. Treatment of ascites and spontaneous bacterial. Dan Med J 2012;59(1).
Koulaouzidis A, Bhat S, Saeed A. Spontaneous bacterial peritonitis. World J Gastroenterol 2009 March 7; 15(9): 1042-1049.
Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: A severe complication of liver cirrhosis. World J Gastroenterol 2009 November 28; 15(44): 5505-5510.
Kraja B, Sina M, Mone I, Pupuleku F, Babameto A, Prifti S, Burazeri G. Predictive Value of theModel of End-Stage Liver Disease in Cirrhotic Patients with and without 33 Spontaneous Bacterial Peritonitis. Gastroenterology Research and Practice Volume 2012, Article ID 539059, 5 pages.
Garzón M, Granados C, Martinez J, Rey M, Molano J, Guevara L, Marulanda J. Ascitis cirrótica y sus complicaciones en un hospital de referencia departamental. Rev Colomb Gastroenterol 2004;19:86-93.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Asrani S, Kamath P, Pedersen R, et al. Liver related mortality in the US is underestimated. Hepatology 2010; 52:408; A169.
Garcia-Tsao et al. Management and treatment of patients with cirrhosis and portal hypertension. Am J Gastroenterol 2009; 104:1802–1829.
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology 2010 vol. 53: 397–417.
Fernadez J, Gustot T. Managment of bacterial infections in cirrhosis. Journal of Hepatology 2012, S1–S12.
Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorganic failure in cirrhosis. Semin Liver Dis 2008;28:26–42.
Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med (2010) 5 (Suppl 1):S37–S44
Koulaouzidis A, Bhat S, Karagiannidis A, Tan W, Linaker B. Spontaneous bacterial peritonitis Postgrad Med J 2007;83:379–383.
France ́s R, Muñoz C, Zapater P, et al. Bacterial DNA activates cell mediated immune response and NO overproduction in peritoneal macrophage from patients with cirrhosis and ascites. Gut 2004;53:860–4.
Horinek E, Fish D. Spontaneous bacterial peritonitis. Advanced critical care 2009 Vol 20 No 2 April-June.
Such J, Ruyon B. Spontaneous bacterial peritonitis. Clinical infectious diseases 1998;27:669-76.
Desai A, Reau N, Reddy G, Te H, Mohanty S, Satoskar R, DeVoss A, Jensen D. Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease. Ther Adv Gastroenterol (2010) 5(5) 275–283.
Deschênes M, Villeneuve J. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol 1999;94:2193-2197. 14)Bhat G, Vandana K, Bhatia S, Suvarna D, Pai C. Spontaneous ascetic fluid infection in liver cirrhosis bacteriological profile and response to antibiotic therapy. Indian J Gastroenterol. 2013 Mar 21.
Tandon P, Delisle A, Topla J Garcia-Tsao G. High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center. Clinical gastroenterology and hepatology 2012; 10:1291–1298.
Riggio O, Angeloni S. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis. World J Gastroenterol 2009 August 21; 15(31): 3845-3850.
Navasa M, Casafont F, Clemente G, Guarner C, de la Mata M, Planas R, Solà R, Suh J Consenso sobre peritonitis bacteriana espontánea en la cirrosis hepática: diagnóstico, tratamiento y profilaxis. Gastroenterol Hepatol 2001; 24: 37-46.
Abd Elaal M, Zaghloul S Gouda Bakr H, Abdou Ashour M, Hady H, Khalifa N, Amr G. Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis. Arab Journal of Gastroenterology 13 (2012) 65–70.
Said A. Al-Busafi, McNabb J, Farag A, Hilzenrat N. Clinical Manifestations of Portal Hypertension International Journal of Hepatology. Vol 2012, Article ID 203794, 10 pages.
Bendtsen F, Grønbæk H, Bach J, Aagaard N, Schmidt L, Møller S. Treatment of ascites and spontaneous bacterial. Dan Med J 2012;59(1).
Koulaouzidis A, Bhat S, Saeed A. Spontaneous bacterial peritonitis. World J Gastroenterol 2009 March 7; 15(9): 1042-1049.
Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: A severe complication of liver cirrhosis. World J Gastroenterol 2009 November 28; 15(44): 5505-5510.
Kraja B, Sina M, Mone I, Pupuleku F, Babameto A, Prifti S, Burazeri G. Predictive Value of theModel of End-Stage Liver Disease in Cirrhotic Patients with and without 33 Spontaneous Bacterial Peritonitis. Gastroenterology Research and Practice Volume 2012, Article ID 539059, 5 pages.
Garzón M, Granados C, Martinez J, Rey M, Molano J, Guevara L, Marulanda J. Ascitis cirrótica y sus complicaciones en un hospital de referencia departamental. Rev Colomb Gastroenterol 2004;19:86-93.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La peritonitis bacteriana espontanea es la infección más frecuente en pacientes cirróticos causado generalmente por Escherichia coli. Existen factores de riesgo relacionados con la aparición y recurrencia de infección peritoneal p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8bb6b38c72b22b9a393832b1b1aa48
http://repository.urosario.edu.co/handle/10336/4987
http://repository.urosario.edu.co/handle/10336/4987